Hologic, Inc. (HOLX.OB) Reports Second Quarter Financials
Hologic, Inc. (HOLX), a diversified medical technologies company serving the healthcare needs of women, recently reported its second quarter financials, which included revenues of $431 million and an estimated $189.2 million from a new product line acquired through a merger with Cytyc Corporation in October 2007. The results were a 138 percent increase from the second quarter in 2007, which reported $181.1 million in revenue. Net income also increased from $21.6 million in 2007 to $56.0 million in 2008, which equates to $0.20 per diluted share in 2007 to $0.22 per diluted share in 2008. Charges related to the merger…
